Clinical Trial Update: Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 trial evaluated the safety, efficacy, and pharmacokinetics of boron neutron capture therapy (BNCT) for recurrent high-grade gliomas. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• High-grade Glioma

Drugs mentioned

• BNCT (boron neutron capture therapy) (boron neutron capture therapy)

Snippet

Sponsor: Dawonmedax Co., Ltd. | Conditions: Recurrent High-grade Glioma, Recurrent Glioblastoma | Phase 1, Phase 2 | Status: TERMINATED